AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022
Amyris, Inc. (Nasdaq: AMRS) announced participation in three investor conferences from May 23 to May 25, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amyris, Inc. (Nasdaq: AMRS) announced participation in three investor conferences from May 23 to May 25, 2022. The events include the Morgan Stanley Sustainable Futures Conference, Cowen 6th Annual Future of the Consumer Conference, and UBS Global Healthcare Conference. These conferences will enhance Amyris's visibility in the sustainable consumption sector and showcase its Lab-to-Market™ technology platform, which leverages machine learning and robotics to innovate rapidly. Live webcasts of the presentations will be available on the company's Investor Relations website.
Positive
- Participation in three prominent investor conferences enhances visibility.
- Showcases Lab-to-Market™ technology, potentially attracting investors.
Negative
- None.
Details
News Market Reaction – AMRS
The recorded move for AMRS in the trading session of this news was -6.03%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management is participating in fireside chats at the following investor conferences this week:
- Morgan Stanley Sustainable Futures Conference, Monday, May 23 at 2:00 PM ET (virtual)
- Cowen 6th Annual Future of the Consumer Conference, Tuesday, May 24 at 10:40 AM ET (in-person)
- UBS Global Healthcare Conference, Wednesday, May 25 at 11:30 AM ET (in-person)
Live webcasts of the presentations and replays will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.
Amyris, the Amyris logo, and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or other countries.
View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-participates-in-investor-conferences-on-may-23-24-and-25-2022-301553283.html
SOURCE Amyris, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.